Back
KalVista Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
KALV
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
66
KALV
KalVista Pharmaceuticals
Last Price:
12.13
Seasonality Move:
-5.6%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.KalVista Pharmaceuticals Price Quote
$12.13
KalVista Pharmaceuticals Key Stats
Buy
66
KalVista Pharmaceuticals (KALV)
is a Buy
Day range:
$11.96 - $12.48
52-week range:
$7.21 - $16.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.94
P/B ratio:
5.78%
Volume:
199.7K
Avg. volume:
466.8K
1-year change:
32.28%
Market cap:
$511.7M
Revenue:
$0
EPS:
$-3.15
How Much Does KalVista Pharmaceuticals Make?
Data Unavailable
Is KalVista Pharmaceuticals Growing As A Company?
Data Unavailable
KalVista Pharmaceuticals Stock Price Performance
-
Did KalVista Pharmaceuticals Stock Go Up Last Month?
KalVista Pharmaceuticals share price went up by 7.73% last month -
Did KALV's Share Price Rise Over The Last Year?
KALV share price rose by 32.28% over the past 1 year
What Is KalVista Pharmaceuticals 52-Week High & Low?
-
What Is KalVista Pharmaceuticals’s 52-Week High Share Price?
KalVista Pharmaceuticals has traded as high as $16.88 over the past 52 weeks -
What Is KalVista Pharmaceuticals’s 52-Week Low Share Price?
KalVista Pharmaceuticals has traded as low as $7.21 over the past 52 weeks
KalVista Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy KalVista Pharmaceuticals?
-
How Much Debt Does KalVista Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does KalVista Pharmaceuticals Have?
Cash and short term investments quarterly total is $75.6M -
What Is KalVista Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.56
Is KalVista Pharmaceuticals Cash Flow Positive?
-
What Is KALV Cash Flow From Operations?
Cash flow from operations (TTM) is -$96.8M -
What Is KalVista Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $583K -
What Is KalVista Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $35.3M
KalVista Pharmaceuticals Return On Invested Capital
Data Unavailable
KalVista Pharmaceuticals Earnings Date & Stock Price
-
What Is KalVista Pharmaceuticals's Stock Price Today?
A single share of KALV can be purchased today for 12.13 -
What Is KalVista Pharmaceuticals’s Stock Symbol?
KalVista Pharmaceuticals trades on the nasdaq under the ticker symbol: KALV -
When Is KalVista Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for KalVista Pharmaceuticals is scheduled on June 14, 2024 -
When Is KALV's next ex-dividend date?
KalVista Pharmaceuticals's next ex-dividend date is May 7, 2024 -
How To Buy KalVista Pharmaceuticals Stock?
You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
KalVista Pharmaceuticals Competitors
-
Who Are KalVista Pharmaceuticals's Competitors?
Below is a list of companies who compete with KalVista Pharmaceuticals or are related in some way:
KalVista Pharmaceuticals Dividend Yield
Data Unavailable
KalVista Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -6.55% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 29.80 |
Upside from Last Price: | 145.67% |